The UN will soon unveil a new global science panel on #AMR - what can we do to make it effective and efficient? See the great papers from our conference in Lagos earlier this year: www.cgdev.org/project/buil...

Are you a researcher working in infectious diseases or #AMR, from a social science discipline (broadly interpreted?). INAMRSS has 3 great opportunities for you! www.globalstrategylab.org/events/open-... Abstract submission open now - move fast!

Issac Weldon from Univ Copenhagen describing what #AMR can learn from environmental governance www.youtube.com/watch?v=f4OS... based on our recent article w Kathleen Liddell (Univ Cambridge) in Milbank: pubmed.ncbi.nlm.nih.gov/40876865/

The world needs better science to fight drug-resistant infections. #amr www.cgdev.org/blog/amr-pan...

How should the new Independent Panel on Evidence for Action on #AMR be set up? We gathered scientists and stakeholders - mainly from Africa - to think this through in Lagos, Nigeria. Pre-print now available: verixiv.org/articles/2-2...

Who should pay for #AMR innovation? www.sciencedirect.com/science/arti... @akesselheim.bsky.social

New funding opportunity opened today for Gram-negative antibacterial discovery (as late as LO) in therapeutics! gcgh.grandchallenges.org/challenge/in...

Welcome

This law student note presumes that important zoonotic jumps from animals to humans occur in the USA, leading to a recommendation to more tightly regulate live animal importation. For most salient examples, such as COVID and HIV/AIDS, zoonotic transmission was outside the USA.

Which lessons can be learned from prior international science panels? How can this help the new Independent Panel on Evidence for Action on AMR? www.cgdev.org/blog/chartin...

@chddd.bsky.social Univ Vienna, spoke today at the British Academy on his research on the antibiotic pipeline, proposes a new triad of how we could think about success.

@chddd.bsky.social Univ Vienna, spoke today at the British Academy on his research on the antibiotic pipeline, proposes a new triad of how we could think about success.

Dr Sonia Lewycka on equity discourse in AMR. Most AMR deaths are in lower income settings, so solutions must center equity. (Un)intended Consequences conf @ British Academy.

Nice way to transform Reviewer 2 comments into a paper!

I also have concerns about the equities of this system

Academic Twitter found a new home. More Bluetorials, please. Any regrets from how the tenure system operates?

Do we have an AMR group?

Access to essential medicines is not improving over the past 4 decades with existing tools. "The gap between richer (high- and upper-middle-income) and poorer (lower-middle- and low-income) countries remained largely unchanged over time." www.healthaffairs.org/doi/epdf/10....

Most cervical cancer deaths are in lower-income settings worldwide; rollout of the vaccines there has been painfully slower than high-income countries. Bring this good thing to more people.

15 years data on infections from the US VA: www.thelancet.com/journals/lan... My 3 takeaways: (1) Infection prevention and control works; (2) We still need better antibiotics; and (3) the choice of the denominator in such studies should be carefully made www.thelancet.com/journals/lan...

Bacteria adapt to take advantage of human weaknesses and situations, including war. We should not be surprised that the bacteria rule the battlefield. www.nytimes.com/2024/11/26/m...

Research is of limited use unless communicated - thanks for this 1 pager

Analysis like this systematic review from 5 years ago is needed to move AMR policy forward in the era of an Independent Panel on Evidence For Action on AMR. #IPEA-AMR Here, a careful critique of methodology choices in studies reporting the economic costs of AMR. link.springer.com/article/10.1...

When azithromycin is overused in high-income countries, no one tries to stop life-saving treatments. 1/2 www.nejm.org/doi/full/10....

In 3 large hospitals in Chile, a retrospective analysis of patients with blood stream infections found around a third of patients received inappropriate empiric antibacterial therapy, with higher in-hospital mortality and costs. bmjpublichealth.bmj.com/content/2/2/...

Every university, TBH